Aug 11, 2026
Computationally Designed Nanoparticle Platform Enhances Influenza Vaccine Immunity
Researchers from the Institute of Biophysics have developed a new protein nanoparticle platform called I53cs. Designed using artificial intelligence (AI), I53cs demonstrated promising performance in animal studies and offers a versatile approach for developing next-generation vaccines.
Bioengineering;Artificial Intelligence